Related Experiment Video
Updated: Jul 5, 2025

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
miR-345-3p Modulates M1/M2 Macrophage Polarization to Inhibit Inflammation in Bone Infection via Targeting MAP3K1 and
Yan Dai1, Xiaolan Yi1, Yahui Huang1
1Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Abstract:
Infection after fracture fixation (IAFF), a complex infectious disease, causes inflammatory destruction of bone tissue and poses a significant clinical challenge. miR-345-3p is a biomarker for tibial infected nonunion; however, the comprehensive mechanistic role of miR-345-3p in IAFF is elusive. In this study, we investigated the role of miR-345-3p in IAFF pathogenesis through in vivo and in vitro experiments. In vivo, in a rat model of IAFF, miR-345-3p expression was downregulated, accompanied by increased M1 macrophage infiltration and secretion of proinflammatory factors. In vitro, LPS induced differentiation of primary rat bone marrow-derived macrophages into M1 macrophages, which was attenuated by miR-345-3p mimics. miR-345-3p promoted M1 to M2 macrophage transition-it reduced the expression of cluster of differentiation (CD) 86, inducible NO synthase, IL-1β, and TNF-α but elevated those of CD163, arginase-1, IL-4, and IL-10. MAPK kinase kinase 1 (MAP3K1), a target mRNA of miR-345-3p, was overexpressed in the bone tissue of IAFF rats compared with that in those of the control rats. The M1 to M2 polarization inhibited MAP3K1 signaling pathways in vitro. Conversely, MAP3K1 overexpression promoted the transition from M2 to M1. miR-345-3p significantly inhibited NF-κB translocation from the cytosol to the nucleus in a MAP3K1-dependent manner. In conclusion, miR-345-3p promotes the polarization of M1 macrophages to the M2 phenotype by inhibiting the MAP3K1 and NF-κB pathways. These findings provide insight into the pathogenesis and immunotherapeutic strategies for IAFF and offer potential new targets for subsequent research.
Insights
MicroRNA-345-3p (miR-345-3p) combats infection after fracture fixation by shifting M1 macrophages to M2. This process inhibits MAP3K1 and NF-κB pathways, offering new therapeutic targets for this bone infection.
Area of Science:
- Biomedical Science
- Immunology
- Molecular Biology
Background:
- Infection after fracture fixation (IAFF) is a severe complication causing bone destruction.
- MicroRNA-345-3p (miR-345-3p) is a known biomarker for tibial infected nonunion, but its precise role in IAFF pathogenesis is unclear.
Purpose of the Study:
- To elucidate the mechanistic role of miR-345-3p in the pathogenesis of IAFF.
- To investigate how miR-345-3p influences macrophage polarization and related signaling pathways in IAFF.
Main Methods:
- Utilized in vivo rat models of IAFF and in vitro experiments with bone marrow-derived macrophages.
- Assessed macrophage polarization markers (M1/M2), cytokine expression, and signaling pathway activation (MAP3K1, NF-κB).
- Investigated the effect of miR-345-3p mimics and MAP3K1 manipulation on macrophage phenotype and inflammatory responses.
Main Results:
- IAFF in rats showed decreased miR-345-3p expression, increased M1 macrophages, and elevated pro-inflammatory factors.
- miR-345-3p promoted M1 to M2 macrophage polarization, reducing M1 markers (CD86, TNF-α) and increasing M2 markers (CD163, IL-10).
- miR-345-3p inhibited the MAP3K1/NF-κB signaling pathway, which was crucial for M1 macrophage polarization.
Conclusions:
- miR-345-3p plays a protective role in IAFF by promoting M2 macrophage polarization via the MAP3K1 and NF-κB pathways.
- These findings highlight miR-345-3p as a potential therapeutic target for managing IAFF.
- Understanding this mechanism offers insights into novel immunotherapeutic strategies for bone infections.
More Related Videos
08:37Polarization and Characterization of M1 and M2 Human Monocyte-Derived Macrophages on Implant Surfaces
Published on: December 6, 2024
07:45Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis
Published on: November 28, 2015